20 August 2026
A Moderna-Merck melanoma vaccine reduces recurrence and spread in a late-stage trial, boosting hopes for mRNA cancer treatments.
11 June 2026
Uncover the potential of mRNA vaccines that show promise for personalized cancer treatments that target tumor cells effectively.
16 February 2026
Moderna criticises the FDA as unpredictable, impacting its mRNA flu shot and the future of drug innovation in America.